Virtu Financial’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.27M Buy
2025
Q1
$180K Buy
2024
Q4
Sell
2024
Q3
$247K Sell
2024
Q2
$409K Sell
2024
Q1
$662K Buy
2023
Q3
Sell
2023
Q2
$203K Buy